KRMD Sygnały na żywo | Maksymalizuj zyski z Getagraph.com

Live Chart Being Loaded With Signals

Commentary (1 liep. 2024 @ 18:16):
Our systems believe the stock currently is undervalued by 0.20% compare to its pairs and should correct upwards.

KORU Medical Systems, Inc. designs, manufactures, and markets portable medical devices primarily for the ambulatory infusion market in the United States and internationally...

Stats
Dzisiejszy wolumen	81 723
Średni wolumen	209 241
Kapitalizacja rynkowa	109.38M
EPS	$-0.0424 ( Q1 \| 2024-05-01 )
Następna data zysków	( $-0.0400 ) 2024-08-14
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-8.24 (Sector) 42.63 (Industry) 0
ATR14	$0.0130 (0.54%)

AKYA -5.56%

ANGO -2.48%

APR 0.00%

ATRC -0.75%

ATRI -0.08%

ATRS 0.18%

AVGR -2.49%

AZTA -1.16%

BLFS -1.49%

EKSO 0.47%

FEMY 0.00%

GMVD 1.38%

HBIO -0.70%

HOLX 0.17%

ICUI -1.56%

IIN 0.12%

ISRG -0.86%

KRMD -9.81%

LMAT -0.08%

LMNX 0.00%

MASI -7.69%

MBOT -1.96%

MHUA 12.15%

MMSI 0.23%

NEPH 0.96%

NSTG -37.43%

NVCR -0.58%

NXGL 0.85%

OSUR 0.70%

PDEX 3.92%

PLSE 1.47%

POAI -0.96%

QDEL -1.90%

RGEN -0.98%

SDC -53.45%

SMTI -3.61%

STAA 0.29%

STSS -3.13%

UTMD -0.08%

XRAY 0.46%

ZTEK 4.90%

Insider Trading

Date	Person	Action	Amount	type
2024-03-31	Manko Joseph M. Jr.	Buy	6 329	Common Stock
2024-03-31	Wholihan Edward	Buy	6 329	Common Stock
2024-03-31	Matin Shahriar	Buy	6 329	Common Stock
2024-03-31	French Donna	Buy	6 329	Common Stock
2024-03-31	Fletcher R John	Buy	9 493	Common Stock

INSIDER POWER
-34.95
Last 100 transactions
Buy: 2 490 287 \| Sell: 4 243 724

Korelacja (AI algo v.1.1b): Undervalued: 0.20% $2.39 paired level. (Algorytm śledzi zmiany najbardziej skorelowanych akcji w czasie rzeczywistym i natychmiast aktualizuje)

Wolumen Korelacja

Długi: 0.09 (neutral)

Krótki: 0.00 (neutral)

Signal:(26.791) Neutral

Repro Med Systems Inc Korelacja

10 Najbardziej pozytywne korelacje

10 Najbardziej negatywne korelacje

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Repro Med Systems Inc Korelacja - Waluta/Towar

0.17
( neutral )

-0.48
( neutral )

0.00
( neutral )

0.84
( strong )

-0.69
( moderate negative )

-0.67
( moderate negative )

Repro Med Systems Inc Finanse

Annual	2023
Przychody:	$28.52M
Zysk brutto:	$15.84M (55.54 %)
EPS:	$-0.300

FY	2023
Przychody:	$28.52M
Zysk brutto:	$15.84M (55.54 %)
EPS:	$-0.300

FY	2022
Przychody:	$27.90M
Zysk brutto:	$15.37M (55.09 %)
EPS:	$-0.190

FY	2021
Przychody:	$23.49M
Zysk brutto:	$13.77M (58.62 %)
EPS:	$-0.100

Financial Reports:

No articles found.

Repro Med Systems Inc Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Repro Med Systems Inc

KORU Medical Systems, Inc. designs, manufactures, and markets portable medical devices primarily for the ambulatory infusion market in the United States and internationally. It offers mechanical infusion product comprising the FREEDOM infusion systems that include the FREEDOM60 syringe driver, the FreedomEdge syringe driver, HIgH-Flo subcutaneous safety needle sets, and precision flow rate tubing. The company also provides education and training materials to clinicians, patients, and patient advocates. It sells its products through direct sales and medical device distributors, as well as online. KORU Medical Systems, Inc. was incorporated in 1980 and is headquartered in Chester, New York.